Identification Generic Name (1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine DrugBank Accession Number DB02367 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine (DB02367) ×  Close Weight Average: 435.516  Monoisotopic: 435.113391549  Chemical Formula C 16 H 25 N 3 O 7 S 2 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Stromelysin-1 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as proline and derivatives. These are compounds containing proline or a derivative thereof resulting from reaction of proline at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Kingdom Organic compounds Super Class Organic acids and derivatives Class Carboxylic acids and derivatives Sub Class Amino acids, peptides, and analogues Direct Parent Proline and derivatives Alternative Parents Alpha amino acid amides  /  Benzenesulfonamides  /  Benzenesulfonyl compounds  /  Pyrrolidinecarboxamides  /  Phenoxy compounds  /  Phenol ethers  /  Alkyl aryl ethers  /  Organosulfonamides  /  Organic sulfonamides  /  Aminosulfonyl compounds  /  Hydroxamic acids  /  Azacyclic compounds  /  Hydrocarbon derivatives  /  Organopnictogen compounds  /  Organic oxides  /  Organonitrogen compounds  /  Carbonyl compounds 
 
 
  show 7 more Substituents Alkyl aryl ether  /  Alpha-amino acid amide  /  Aminosulfonyl compound  /  Aromatic heteromonocyclic compound  /  Azacycle  /  Benzenesulfonamide  /  Benzenesulfonyl group  /  Benzenoid  /  Carbonyl group  /  Ether  /  Hydrocarbon derivative  /  Hydroxamic acid  /  Monocyclic benzene moiety  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organic sulfonic acid amide  /  Organic sulfonic acid or derivatives  /  Organoheterocyclic compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Organosulfonic acid amide  /  Organosulfonic acid or derivatives  /  Organosulfur compound  /  Phenol ether  /  Phenoxy compound  /  Proline or derivatives  /  Pyrrolidine  /  Pyrrolidine carboxylic acid or derivatives  /  Pyrrolidine-2-carboxamide  /  Sulfonyl 
 
 
  show 22 more Molecular Framework Aromatic heteromonocyclic compounds External Descriptors sulfonamide, N-acylpyrrolidine, D-proline derivative, pyrrolidinehydroxamic acid ( CHEBI:39531 )  Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key ULDXUWXTVRRUND-SWLSCSKDSA-N InChI InChI=1S/C16H25N3O7S2/c1-3-4-9-26-13-5-7-14(8-6-13)28(24,25)19-11-12(18-27(2,22)23)10-15(19)16(20)17-21/h5-8,12,15,18,21H,3-4,9-11H2,1-2H3,(H,17,20)/t12-,15+/m0/s1 IUPAC Name (2R,4S)-1-(4-butoxybenzenesulfonyl)-N-hydroxy-4-methanesulfonamidopyrrolidine-2-carboxamide SMILES CCCCOC1=CC=C(C=C1)S(=O)(=O)N1C[C@H](C[C@@H]1C(=O)NO)NS(C)(=O)=O References General References Not Available External Links PubChem Compound 5287415 PubChem Substance 46506803 ChemSpider 4449804 BindingDB 50095567 ChEMBL CHEMBL358064 ZINC ZINC000003870354 PDBe Ligand 111 PDB Entries 1g49 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.459 mg/mL ALOGPS logP 0.2 ALOGPS logP -0.46 Chemaxon logS -3 ALOGPS pKa (Strongest Acidic) 8.71 Chemaxon pKa (Strongest Basic) -4.9 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 7 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 142.11 Å 2 Chemaxon Rotatable Bond Count 7 Chemaxon Refractivity 101.32 m 3 ·mol -1 Chemaxon Polarizability 43.62 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9756 Blood Brain Barrier - 0.6509 Caco-2 permeable - 0.6781 P-glycoprotein substrate Substrate 0.7046 P-glycoprotein inhibitor I Non-inhibitor 0.6823 P-glycoprotein inhibitor II Non-inhibitor 0.6311 Renal organic cation transporter Non-inhibitor 0.8827 CYP450 2C9 substrate Non-substrate 0.6024 CYP450 2D6 substrate Non-substrate 0.7768 CYP450 3A4 substrate Substrate 0.588 CYP450 1A2 substrate Non-inhibitor 0.8116 CYP450 2C9 inhibitor Non-inhibitor 0.6106 CYP450 2D6 inhibitor Non-inhibitor 0.8932 CYP450 2C19 inhibitor Non-inhibitor 0.6442 CYP450 3A4 inhibitor Non-inhibitor 0.6055 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.8307 Ames test Non AMES toxic 0.5939 Carcinogenicity Non-carcinogens 0.7229 Biodegradation Not ready biodegradable 0.9762 Rat acute toxicity 2.4873 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9719 hERG inhibition (predictor II) Non-inhibitor 0.5641    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more Binding Properties × Property Measurement pH Temperature (°C) References IC 50 (nM) 16 N/A N/A A29906 
 
 
  Details 
 
 
   Binding Properties 1.  Stromelysin-1 Kind Protein Organism Humans Pharmacological action Unknown General Function Zinc ion binding Specific Function Can degrade fibronectin, laminin, gelatins of type I, III, IV, and V; collagens III, IV, X, and IX, and cartilage proteoglycans. Activates procollagenase. Gene Name MMP3 Uniprot ID P08254 Uniprot Name Stromelysin-1 Molecular Weight 53976.84 Da References Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [ Article ]  Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at June 13, 2005 13:24 / Updated at July 02, 2020 13:15 